Stress ulcer prophylaxis: Is mortality a useful endpoint?

Intensive Care Med. 2020 Nov;46(11):2058-2060. doi: 10.1007/s00134-020-06250-9. Epub 2020 Sep 28.

Authors

Armin Finkenstedt¹, Mette M Berger², Michael Joannidis³

Affiliations

¹ Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
² Adult Intensive Care Service, Lausanne University Hospital, Lausanne, Switzerland.
³ Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. [email protected].

PMID: 32989489
DOI: 10.1007/s00134-020-06250-9

No abstract available

Publication types

Editorial
Comment

MeSH terms

Critical Illness*
Gastrointestinal Hemorrhage
Histamine H2 Antagonists
Humans
Network Meta-Analysis
Randomized Controlled Trials as Topic
Ulcer*

Substances

Histamine H2 Antagonists